Note de episod
Cognitive peptides have become one of the loudest conversations in the nootropic and longevity space, and one of the least understood. Dr. Sasha Rose and Colin Renaud, PA-C talk through Selank and Semax: what they are, what the research has actually evaluated, and where the honest limits sit.
Colin is careful with the evidence. Much of what exists is laboratory and animal work. Some human trials were conducted in Russia. Semax only recently entered the FDA compounding conversation when the Pharmacy Compounding Advisory Committee discussed Semax-related substances. Animal data on BDNF is a…
Site: share.transistor.fm

